Response of high blood glucose level to GTEM cell electromagnetic fields to simulate cell phone radiation

2012 ◽  
Author(s):  
N. Boriraksantikul ◽  
N. E. Islam ◽  
K. D. Bhattacharyya ◽  
P. J. Whiteside ◽  
J. A. Viator ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Electromagnetic Fields ◽  
Glucose Level ◽  
Cell Phone ◽  
High Blood Glucose ◽  
High Blood Glucose Level ◽  
Gtem Cell ◽  
Cell Phone Radiation

scholarly journals Diabetes in COVID-19 patients: challenges and possible management strategies

2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Riyan Al Islam Reshad ◽  
Sumaiya Hafiz Riana ◽  
Mohammad Al-baruni Chowdhury ◽  
Abu Tayab Moin ◽  
Faruque Miah ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Healthy Lifestyle ◽  
Management Strategies ◽  
Diabetic Patients ◽  
Main Body ◽  
High Blood Glucose ◽  
High Blood Glucose Level ◽  
Global Population

Abstract Background The recent pandemic of coronavirus disease 19 (COVID-19) has been causing intense stress among the global population. In the case of hospitalized and ICU-admitted COVID-19 patients with comorbidities, it has been observed that a major portion of them are diabetic. Therefore, researchers had indicated a link between diabetes mellitus (DM) and COVID-19. Furthermore, DM is a potential risk factor for the severity of COVID-19 cases. Thus, in this study, the correlation existing between diabetic patients and COVID-19 was summarized. Main body of the abstract Diabetic patients have a weaker immune system, less viral clearance rate, malfunctions of metabolic activity due to their high blood glucose level, and other associated problems. This does not increase the susceptibility for the patients to be infected with COVID-19. However, the severity of COVID-19 can worsen due to the comorbidity of DM. Short conclusion Proper management, appropriate use of drugs that do not increase the ACE2 expression, lowering blood glucose level, decreasing the susceptibility of SARS-CoV-2, and maintaining a healthy lifestyle could be effective.

scholarly journals Metabolome of Cerebral Thrombi Reveals an Association between High Glycemia at Stroke Onset and Good Clinical Outcome

Metabolites ◽  
2020 ◽  
Vol 10 (12) ◽  
pp. 483
Author(s):  
Laurent Suissa ◽  
Jean-Marie Guigonis ◽  
Fanny Graslin ◽  
Emilie Doche ◽  
Ophélie Osman ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Discriminant Analysis ◽  
Clinical Outcome ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Area Under The Curve ◽  
Stroke Onset ◽  
Stroke Patients ◽  
High Blood Glucose ◽  
High Blood Glucose Level

Despite the fact that glucose is the main fuel of the brain, hyperglycemia at hospital admission is generally associated with a poor functional outcome in stroke patients. This paradox may be explained by the lack of information about the blood glucose level at stroke onset. Here, we analyzed the metabolome of blood cells entrapped in cerebral thrombi to gain insight into their metabolism at stroke onset. Fourty-one consecutive stroke patients completely recanalized by mechanical thrombectomy within 6 h were included. The metabolome of retrieved thrombi was analyzed by liquid chromatography tandem with mass spectrometry. Discriminant Analysis (sparse Partial Least Squares Discriminant Analysis (sPLS-DA)) was performed to identify classification models and significant associated features of favorable clinical outcome at 3 months (modified Rankin Scale (mRS) < 2). sPLS-DA of the metabolomes of cerebral thrombi discriminated between stroke patients with a favorable or poor clinical outcome (Area Under the Curve (AUC) = 0.992 (0.931–1)). In addition, our results revealed that high sorbitol and glucose levels in the thrombi positively correlated with favorable clinical outcomes. Sorbitol, a short-term glycemic index reflecting a high blood glucose level at stroke onset, was found to be an independent predictor of good outcome (AUC = 0.908 (0.807–0.995)). This study demonstrates that a high blood glucose level at stroke onset is beneficial to the clinical outcome of the patient.

scholarly journals Healing of Extraction Socket in Diabetic Patients- A Hospital based Retrospective Study

2020 ◽  
Vol 11 (SPL3) ◽  
pp. 1427-1430
Author(s):  
Chidambaram Shathviha P ◽  
Herald J Sherlin ◽  
Mebin Mathew
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Healing Process ◽  
Diabetic Patients ◽  
Age Group ◽  
High Blood Glucose ◽  
High Blood Glucose Level ◽  
Surgical Extraction ◽  
Extraction Treatment

Diabetes is a common metabolic disorder which is an inability to regulate blood glucose due to insulin deficiency or resistance. During extraction, diabetic patients suffer various complications. One among them is most commonly seen delayed wound healing. The aim of this study is to evaluate the prevalence of delay in the healing process of extraction sockets in diabetic patients. This retrospective cross-sectional study was carried out in a hospital setting where all case sheets for six months were filtered from the patient management software. Samples of all patients with diabetes and the extraction treatment were filtered. Three hundred sixteen patients were used for this study. The data is collected and imported to SPSS for statistical analysis and results are obtained. Among 316 patients, 77 were diabetic and had undergone extraction treatment. Satisfactory healing was observed in diabetic patients undergoing normal extraction within the age group 60-70 years and with blood glucose level within normal range (54%). Unhealed sockets were observed in diabetic patients who underwent surgical extraction within the age group of 60-70 years and with high blood glucose level (10.2%). Majority of patients with normal blood glucose level have satisfactory healing and patients with high blood glucose level have unhealed sockets. Dentists should be aware that diabetic patients of poor glucose control undergoing traumatic extraction are prone to delayed healing processes which lead the patient to discomfort and infections. Patients should be advised to have a proper diet and controlled level of glucose to prevent oral complications.

scholarly journals Incidence Hypertension and Fasting Blood Glucose from Real-World Data: Retrospective Cohort for 7-Years Follow-Up

2021 ◽  
Vol 18 (4) ◽  
pp. 2085
Author(s):  
Soon-Ki Ahn ◽  
Ju-Mi Lee ◽  
Seon Mi Ji ◽  
Kyoung Hoon Kim ◽  
Jong-Heon Park ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Real World ◽  
Retrospective Cohort ◽  
Fasting Blood Glucose ◽  
Real World Data ◽  
High Blood Glucose ◽  
High Blood Glucose Level ◽  
History Of

This retrospective cohort study was done to investigate the incidence of hypertension and its relation to the fasting blood glucose level in Korea. The eligible non-hypertensive subjects (n = 3,396,187) among the National Health Insurance Service-National Health Screening (NHIS-HEALS) examinees (n = 10,644,911) in 2009 were followed up until 2015. A Cox proportional hazards regression was used to estimate the risk of the high blood glucose level for the incident hypertension while controlling for covariates’ confounding effect. The cumulative incidence rate was 10.6% for seven years (11.6% in men and 8.3% in women). The incidence density was 1474.8 per 100,000 person-years. High fasting blood glucose (adjusted Hazard Ratio (aHR), 1.836; 95% confidence interval (CI), 1.810 to 1.862), prediabetes (aHR, 1.249; 95% CI, 1.237 to 1.260), a history of diabetes mellitus (aHR, 1.635; 95% CI, 1.605 to 1.666), high triglyceride (aHR, 1.292; 95% CI, 1.280 to 1.303), a history of dyslipidemia (aHR, 1.279; 95% CI, 1.253 to 1.305) and prehypertension group (aHR, 1.964; 95% CI, 1.948 to 1.979) were significantly related to the incident hypertension after adjusting for covariates. Among real-world data in Korea, high blood glucose level was the independent risk factor for developing hypertension.

scholarly journals The link between active pulmonary tuberculosis and high blood glucose level

Respiratio ◽  
2017 ◽  
Vol 7 (1-2) ◽  
pp. 86-90
Author(s):  
Vildana Hadžić ◽  
◽  
Emir Abdulović ◽  
Ermin Hasanović ◽  
Emir Halilović ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Pulmonary Tuberculosis ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
High Blood Glucose ◽  
Active Pulmonary Tuberculosis ◽  
High Blood Glucose Level

Galectin-3 mediates high-glucose-induced cardiomyocyte injury by the NADPH oxidase/reactive oxygen species pathway

2020 ◽  
Vol 98 (11) ◽  
pp. 826-833
Author(s):  
Jingang Sun ◽  
Lijuan Zhang ◽  
Jianhai Fang ◽  
Shuguo Yang ◽  
Lianghua Chen
Keyword(s):  
Oxidative Stress ◽  
Blood Glucose ◽  
Nadph Oxidase ◽  
Blood Glucose Level ◽  
Body Mass ◽  
Glucose Level ◽  
High Glucose ◽  
Cardiac Injury ◽  
High Blood Glucose ◽  
Galectin 3

Galectin-3 is a member of the β-galactoside-binding lectin family taking part in the regulation of inflammation, angiogenesis, and fibrosis. This study was designed to study the improved effect of galectin-3 inhibition on diabetic cardiomyopathy (DCM). Sprague–Dawley rats were randomized into the control, DCM, and DCM + modified citrus pectin (MCP) (a galectin–3 pharmacological inhibitor) groups. After 8 weeks, streptozotocin-induced DCM led to high blood glucose level, oxidative stress, cardiac injury, and dysfunction accompanied by suppressed body mass. On the contrary, MCP (100 mg·kg−1·day−1) administration improved body mass and blood glucose level and attenuated cardiac injury and dysfunction in DCM rats. Additionally, MCP attenuated pathological changes in plasma and myocardial tissue markers of oxidative stress, such as hydrogen peroxide and malonyldialdehyde, although it did not change superoxide dismutase activities, which were decreased in the DCM group. The levels of oxidative stress associated proteins evaluated by Western blot, such as p67phox and NADPH oxidase 4, were obviously increased in the DCM group, while they were reversed by MCP treatment. Therefore, galectin-3-mediated high-glucose-induced cardiomyocyte injury and galectin-3 inhibition attenuated DCM by suppressing NADPH oxidase. These findings suggested that galectin-3 could be a potential target for treatment of patients with DCM.

Sign in / Sign up

Export Citation Format

Share Document